V.A.C. Veraflo™ therapy case study competition deadline for entries: Monday 1st November 2019

Share this article

V.A.C. Veraflo™ therapy case study competition deadline for entries: Monday 1st November 2019

1 August 2019

Wounds International and KCI are proud to introduce the V.A.C. VERAFLO™ Therapy (Acelity) case study competition.


Wounds International and KCI are proud to introduce the V.A.C. VERAFLO™ Therapy (Acelity) case study competition.


Download the guidelines click here 

Open to all using V.A.C. VERAFLO™ Therapy (NPWTi-d; Negative Pressure Wound Therapy with instillation and a dwell time), this competition is not seeking the worst of the worst cases, but cases that are representative of your everyday usage of V.A.C. VERAFLO™ Therapy. The winning case studies will be the top three entries that stand out as symbolic or exemplary usage of V.A.C. VERAFLO™ Therapy. The winners will be determined by general acclaim of the peer review independent panelists.

Entries must be case reports that explore and document the clinical results of NPWTi-d and represent your everyday usage of V.A.C. VERAFLO™ Therapy, to encourage continued research and knowledge sharing of recent advances.

To promote knowledge sharing and cross-disciplinary awareness, all entries will be available for open-access peer review.

V.A.C. VERAFLO™ Therapy combines the benefits of NPWT with controlled delivery of topical solutions and suspensions over the wound bed. In addition to reducing oedema and promoting perfusion and granulation tissue formation, the inclusion of instillation therapy assists with wound cleansing by loosening and removing soluble contaminants between dressing changes. It is indicated for patients with chronic, acute, traumatic, subacute and dehisced wounds, partial-thickness burns, ulcers (such as diabetic, pressure and venous insufficiency), flaps and grafts. 

Educational grant to be awarded to the winners’  healthcare organisation
1st Prize: €5,000
2nd Prize: €2,000
3rd Prize: €1,000

Key dates

  • Friday 1st November 2019 – Competition closes
  • Friday 15th November 2019 – Independent expert panel review concludes
  • Friday 29th November 2019  – Case study winners announced


  • Case studies present the details of real patient cases from medical or clinical practice. Cases may contribute significantly to the existing knowledge on the field or showcase less novel results. The goal of case study is to make other researchers aware of the possibility that a specific phenomenon might occur.
  • The case study should contain the following sections: introduction, methods, results, discussion, conclusions, references (if applicable).
  • The case study submitted to this competition should be unpublished and not have been submitted elsewhere. This includes case studies that have previously been presented at conferences or appeared in other ‘non-journal’ venues (for example: blogs or posters).
  • Informed patient consent should be either obtained or waived. Patient anonymity should be maintained.
  • Declarations of interest should be included.
  • Cases should be submitted in English.
  • The word count (including title page, abstract/summary/tables/references) should not exceed 3500 words.
  • Each submission should describe one patient. 
  • Maximum of 3 submissions per clinician or group.
  • The case study should relate to use of  V.A.C. VERAFLO™ Therapy within the approved indications for the device.

All case studies must be submitted and formatted below. Authors are encouraged to include supporting animations and videos within their case study submissions. For additional information, please refer to our Competition entry instructions.

Compliance and Ethics

  • All accepted clinical case studies must be compliant with applicable regulatory, ethics / IRB, and other rules governing protection of human subjects.
  • This competition is not intended to, and shall not, promote or otherwise encourage unapproved, un-cleared use of products or any product for unapproved new use.
  • This competition in no way promotes or purports to encourage any research that is not in compliance with any applicable governing laws, rules or regulations.
  • MedTech Europe

Acelity is a proud member and supporter of MedTech Europe. The MedTech mission is to make innovative medical technology available to more people, while helping healthcare systems move towards a sustainable path. MedTech Europe promotes a balanced policy environment that enables our industry to meet the growing healthcare needs and expectations of our stakeholders. Click here to see the MedTech Code of Ethical Business Practice.


Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.